Technology Transfer

Case Western Reserve University's Technology Transfer Office (TTO) serves our innovators with full-spectrum intellectual property services. For both faculty and students, we provide support for intellectual property and commercialization that spans the research & development continuum. We serve our researchers by assessing and building upon the commercial potential of new ideas and inventions.

Through interaction with our inventors, regional and national networks, including our affiliate healthcare systems, and potential commercial partners, we endeavor to determine the best path of translation and ultimate commercialization for University intellectual assets.

Consistent with the University's mission, the Technology Transfer Office is working towards enhancing its role in the promotion of an inclusive culture of global citizenship by exploring issues of access to essential medicines by resource-limited countries. This work includes moving towards the Universities Allied for Essential Medicine's Global Access Licensing Framework

 

Recent News

PAVmed Subsidiary Lucid Diagnostics Announces Commercial Launch of EsoGuard Esophageal DNA Test

--Globe Newswire December 19, 2019

NervGen Pharma Receives Investment from Drug Manufacturing Partner - CSBio Invests US$1,5000,000 as Part of Manufacturing Contract for Clinical Trial Product

--NervGen Pharma November 18, 2019

CollaMedix - A Biotech Startup Founded with Technology Invented at CWRU and UHCMC - Reaches Exclusive Licensing Agreement

---CWRU Daily October 16, 2019

CWRU and Akouos Sign Exclusive Licensing Agreement to Advance Development of Gene Therapy Technology as a Potential Treatment for a Type of Usher Syndrome

--CWRU Daily September 5, 2019

CWRU Spinout Convelo Partners with San Francisco Company to Develop Medicines for Neurological Disorders

--Crain's Cleveland Business July 30, 2019

 

For Questions About...

  • Your Invention Disclosure Form (IDF), please contact Joy Chen at 216.368.0362.
  • A Material Transfer Agreement (MTA) or a Data Use Agreement (DUA), please contact Walid Jalabi at 216.368.2151.
  • Anything else, please contact Daniel Pendergast at 216.368.0184.